# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-23-147301
Filing Date
2023-05-18
Accepted
2023-05-17 21:32:03
Documents
21
Period of Report
2023-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d499270d8k.htm iXBRL | 8-K | 41116
2 | EX-5.1 | d499270dex51.htm | EX-5.1 | 6812
3 | EX-10.1 | d499270dex101.htm | EX-10.1 | 1572098
4 | EX-10.2 | d499270dex102.htm | EX-10.2 | 176431
5 | EX-99.1 | d499270dex991.htm | EX-99.1 | 4459
9 | GRAPHIC | g499270dsp1.jpg | GRAPHIC | 4184
10 | GRAPHIC | g499270dsp2.jpg | GRAPHIC | 10673
11 | GRAPHIC | g499270dsp3.jpg | GRAPHIC | 2465
12 | GRAPHIC | g499270g0516090057519.jpg | GRAPHIC | 4498
13 | GRAPHIC | g499270g0517220915468.jpg | GRAPHIC | 2887
| Complete submission text file | 0001193125-23-147301.txt |  | 2328626

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | ebs-20230515.xsd | EX-101.SCH | 2874
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | ebs-20230515_lab.xml | EX-101.LAB | 17994
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | ebs-20230515_pre.xml | EX-101.PRE | 11278
15 | EXTRACTED XBRL INSTANCE DOCUMENT | d499270d8k_htm.xml | XML | 3356

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 23933566
SIC: 2834 Pharmaceutical Preparations